Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia.

Schmidt DE, de Haan N, Sonneveld ME, Porcelijn L, van der Schoot CE, de Haas M, Zwaginga JJ, Wuhrer M, Vidarsson G.

Sci Rep. 2020 Feb 20;10(1):3051. doi: 10.1038/s41598-020-59651-7.

2.

Anti-Platelet Antibodies in Childhood Immune Thrombocytopenia: Prevalence and Prognostic Implications.

Schmidt DE, Heitink-Polle KMJ, Porcelijn L, van der Schoot CE, Vidarsson G, Bruin MCA, de Haas M.

J Thromb Haemost. 2020 Feb 13. doi: 10.1111/jth.14762. [Epub ahead of print]

PMID:
32053276
3.

Dietary intake of heme iron is associated with ferritin and hemoglobin levels in Dutch blood donors: results from Donor InSight.

Timmer TC, de Groot R, Rijnhart JJM, Lakerveld J, Brug J, Perenboom CWM, Baart AM, Prinsze FJ, Zalpuri S, van der Schoot CE, de Kort WLAM, van den Hurk K.

Haematologica. 2019 Nov 14. pii: haematol.2019.229450. doi: 10.3324/haematol.2019.229450. [Epub ahead of print]

4.

The Role of Complement in Transfusion-Related Acute Lung Injury.

Jongerius I, Porcelijn L, van Beek AE, Semple JW, van der Schoot CE, Vlaar APJ, Kapur R.

Transfus Med Rev. 2019 Oct;33(4):236-242. doi: 10.1016/j.tmrv.2019.09.002. Epub 2019 Oct 18. Review.

PMID:
31676221
5.

Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile.

De Groot R, Van Loenen MM, Guislain A, Nicolet BP, Freen-Van Heeren JJ, Verhagen OJHM, Van Den Heuvel MM, De Jong J, Burger P, Van Der Schoot CE, Spaapen RM, Amsen D, Haanen JBAG, Monkhorst K, Hartemink KJ, Wolkers MC.

Oncoimmunology. 2019 Aug 15;8(11):e1648170. doi: 10.1080/2162402X.2019.1648170. eCollection 2019.

6.

Fast and low-cost direct ELISA for high-throughput serological HPA-1a typing.

Winkelhorst D, Porcelijn L, Muizelaar E, Oldert G, Huiskes E, van der Schoot CE.

Transfusion. 2019 Sep;59(9):2989-2996. doi: 10.1111/trf.15454. Epub 2019 Jul 22.

PMID:
31329320
7.

Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.

Porcelijn L, Schmidt DE, van der Schoot CE, Vidarsson G, de Haas M, Kapur R.

Haematologica. 2019 Jul 11. pii: haematol.2019.228908. doi: 10.3324/haematol.2019.228908. [Epub ahead of print]

8.

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Schmidt DE, Heitink-Pollé KMJ, Laarhoven AG, Bruin MCA, Veldhuisen B, Nagelkerke SQ, Kuijpers TW, Porcelijn L, van der Schoot CE, Vidarsson G, de Haas M.

Blood Adv. 2019 Jul 9;3(13):2003-2012. doi: 10.1182/bloodadvances.2019000068.

9.

Identification of a novel single-nucleotide mutation in SMIM1 gene that results in low Vel antigen expression.

van der Rijst MVE, Voorn L, Veldhuisen B, Jongerius JM, van den Akker E, van der Schoot CE.

Transfusion. 2019 Oct;59(10):E8-E10. doi: 10.1111/trf.15411. Epub 2019 Jun 19. No abstract available.

PMID:
31218697
10.

Frequency and characterization of RHD variants in serologically D- Surinamese pregnant women and D- newborns.

Zonneveld R, Kanhai HHH, Javadi A, Veldhuisen B, Brand A, Zijlmans WCWR, van der Schoot CE, Schonewille H; Rhesus in Surinamese Neonates (RheSuN) Study Group.

Transfusion. 2019 Aug;59(8):2672-2677. doi: 10.1111/trf.15394. Epub 2019 Jun 10.

PMID:
31183885
11.

Associations between single nucleotide polymorphisms and erythrocyte parameters in humans: A systematic literature review.

Timmer T, Tanck MWT, Huis In 't Veld EMJ, Veldhuisen B, Daams JG, de Kort WLAM, van der Schoot CE, van den Hurk K.

Mutat Res. 2019 Jan - Mar;779:58-67. doi: 10.1016/j.mrrev.2019.01.002. Epub 2019 Feb 2. Review.

PMID:
31097152
12.

Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.

Stapleton NM, Brinkhaus M, Armour KL, Bentlage AEH, de Taeye SW, Temming AR, Mok JY, Brasser G, Maas M, van Esch WJE, Clark MR, Williamson LM, van der Schoot CE, Vidarsson G.

Sci Rep. 2019 May 14;9(1):7363. doi: 10.1038/s41598-019-40731-2.

13.

Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.

Nagelkerke SQ, Tacke CE, Breunis WB, Tanck MWT, Geissler J, Png E, Hoang LT, van der Heijden J, Naim ANM, Yeung RSM, Levin ML, Wright VJ, Burgner DP, Ponsonby AL, Ellis JA, Cimaz R, Shimizu C, Burns JC, Fijnvandraat K, van der Schoot CE, van den Berg TK, de Boer M, Davila S, Hibberd ML, Kuijpers TW; International Kawasaki Disease Genetics Consortium.

Front Immunol. 2019 Mar 21;10:185. doi: 10.3389/fimmu.2019.00185. eCollection 2019.

14.

Development of a recombinant anti-Vel immunoglobulin M to identify Vel-negative donors.

van der Rijst MVE, Lissenberg-Thunnissen SN, Ligthart PC, Visser R, Jongerius JM, Voorn L, Veldhuisen B, Vidarsson G, van den Akker E, van der Schoot CE.

Transfusion. 2019 Apr;59(4):1359-1366. doi: 10.1111/trf.15147. Epub 2019 Jan 31.

PMID:
30702752
15.

Multiplex blood group typing by cellular surface plasmon resonance imaging.

Szittner Z, Bentlage AEH, van der Donk E, Ligthart PC, Lissenberg-Thunnissen S, van der Schoot CE, Vidarsson G.

Transfusion. 2019 Feb;59(2):754-761. doi: 10.1111/trf.15071. Epub 2018 Nov 29.

PMID:
30488958
16.

Elevated monocyte-specific type I interferon signalling correlates positively with cardiac healing in myocardial infarct patients but interferon alpha application deteriorates myocardial healing in rats.

Ter Horst EN, Krijnen PAJ, Hakimzadeh N, Robbers LFHJ, Hirsch A, Nijveldt R, Lommerse I, Fontijn RD, Meinster E, Delewi R, van Royen N, Zijlstra F, van Rossum AC, van der Schoot CE, van der Pouw Kraan TCTM, Horrevoets AJ, van der Laan AM, Niessen HWM, Piek JJ.

Basic Res Cardiol. 2018 Nov 12;114(1):1. doi: 10.1007/s00395-018-0709-7.

17.

Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution.

Kraal KCJM, Timmerman I, Kansen HM, van den Bos C, Zsiros J, van den Berg H, Somers S, Braakman E, Peek AML, van Noesel MM, van der Schoot CE, Fiocco M, Caron HN, Voermans C, Tytgat GAM.

Clin Cancer Res. 2019 Feb 1;25(3):1012-1021. doi: 10.1158/1078-0432.CCR-18-1904. Epub 2018 Oct 12.

18.

A variant RhAG protein encoded by the RHAG*572A allele causes serological weak D expression while maintaining normal RhCE phenotypes.

Wen J, Verhagen OJHM, Jia S, Liang Q, Wang Z, Wei L, Luo H, Luo G, Vidarsson G, van den Akker E, Ji Y, van der Schoot CE.

Transfusion. 2019 Jan;59(1):405-411. doi: 10.1111/trf.14969. Epub 2018 Oct 4.

PMID:
30284303
19.

A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs Incurred.

van Sambeeck JHJ, de Wit PD, Luken J, Veldhuisen B, van den Hurk K, van Dongen A, Koopman MMW, van Kraaij MGJ, van der Schoot CE, Schonewille H, de Kort WLAM, Janssen MP.

Front Med (Lausanne). 2018 Jul 25;5:199. doi: 10.3389/fmed.2018.00199. eCollection 2018.

20.

TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis.

Klamer SE, Dorland YL, Kleijer M, Geerts D, Lento WE, van der Schoot CE, von Lindern M, Voermans C.

Stem Cells Dev. 2018 Nov 1;27(21):1494-1506. doi: 10.1089/scd.2018.0124. Epub 2018 Sep 6.

21.

Correction: Predicting anti-RhD titers in donors: Boostering response and decline rates are personal.

de Vos AS, van der Schoot CE, Rizopoulos D, Janssen MP.

PLoS One. 2018 May 24;13(5):e0198381. doi: 10.1371/journal.pone.0198381. eCollection 2018.

22.

Predicting anti-RhD titers in donors: Boostering response and decline rates are personal.

de Vos AS, van der Schoot CE, Rizopoulos D, Janssen MP.

PLoS One. 2018 Apr 26;13(4):e0196382. doi: 10.1371/journal.pone.0196382. eCollection 2018. Erratum in: PLoS One. 2018 May 24;13(5):e0198381.

23.

ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.

Zwiers C, Koelewijn JM, Vermij L, van Sambeeck J, Oepkes D, de Haas M, van der Schoot CE.

Transfusion. 2018 Jul;58(7):1611-1617. doi: 10.1111/trf.14606. Epub 2018 Apr 6.

PMID:
29624682
24.

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies.

Sonneveld ME, Koeleman CAM, Plomp HR, Wuhrer M, van der Schoot CE, Vidarsson G.

Front Immunol. 2018 Jan 31;9:129. doi: 10.3389/fimmu.2018.00129. eCollection 2018.

25.

Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region.

van de Bovenkamp FS, Derksen NIL, Ooijevaar-de Heer P, van Schie KA, Kruithof S, Berkowska MA, van der Schoot CE, IJspeert H, van der Burg M, Gils A, Hafkenscheid L, Toes REM, Rombouts Y, Plomp R, Wuhrer M, van Ham SM, Vidarsson G, Rispens T.

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1901-1906. doi: 10.1073/pnas.1711720115. Epub 2018 Feb 5.

26.

Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport.

Stapleton NM, Armstrong-Fisher SS, Andersen JT, van der Schoot CE, Porter C, Page KR, Falconer D, de Haas M, Williamson LM, Clark MR, Vidarsson G, Armour KL.

Mol Immunol. 2018 Mar;95:1-9. doi: 10.1016/j.molimm.2018.01.006. Epub 2018 Feb 20.

27.

Vox Sanguinis International Forum on application of fetal blood grouping: summary.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):198-201. doi: 10.1111/vox.12616. Epub 2017 Dec 28. No abstract available.

PMID:
29282745
28.

Vox Sanguinis International Forum on application of fetal blood grouping.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):e26-e35. doi: 10.1111/vox.12615. Epub 2017 Dec 28. No abstract available.

PMID:
29282741
29.

Genotyping to prevent Rh disease: has the time come?

van der Schoot CE, de Haas M, Clausen FB.

Curr Opin Hematol. 2017 Nov;24(6):544-550. doi: 10.1097/MOH.0000000000000379. Review.

PMID:
28937404
30.

RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay.

Ji YL, Luo H, Wen JZ, Haer-Wigman L, Veldhuisen B, Wei L, Wang Z, Ligthart P, Lodén-van Straaten M, Fu YS, van der Schoot CE, Luo GP.

Vox Sang. 2017 Oct;112(7):660-670. doi: 10.1111/vox.12554. Epub 2017 Aug 18.

PMID:
28833187
31.

Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.

Sonneveld ME, de Haas M, Koeleman C, de Haan N, Zeerleder SS, Ligthart PC, Wuhrer M, van der Schoot CE, Vidarsson G.

Sci Rep. 2017 Aug 15;7(1):8187. doi: 10.1038/s41598-017-08654-y.

32.

RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance.

Stegmann TC, Veldhuisen B, Nagelkerke SQ, Winkelhorst D, Schonewille H, Verduin EP, Kuijpers TW, de Haas M, Vidarsson G, van der Schoot CE.

Blood. 2017 Feb 23;129(8):1045-1048. doi: 10.1182/blood-2016-05-716365. Epub 2017 Jan 12. No abstract available.

PMID:
28082442
33.

Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.

Boer JM, Steeghs EM, Marchante JR, Boeree A, Beaudoin JJ, Beverloo HB, Kuiper RP, Escherich G, van der Velden VH, van der Schoot CE, de Groot-Kruseman HA, Pieters R, den Boer ML.

Oncotarget. 2017 Jan 17;8(3):4618-4628. doi: 10.18632/oncotarget.13492.

34.

Validation of the multiplex ligation-dependent probe amplification assay and its application on the distribution study of the major alleles of 17 blood group systems in Chinese donors from Guangzhou.

Ji Y, Wen J, Veldhuisen B, Haer-Wigman L, Wang Z, Lodén-van Straaten M, Wei L, Luo G, Fu Y, van der Schoot CE.

Transfusion. 2017 Feb;57(2):423-432. doi: 10.1111/trf.13940. Epub 2016 Nov 27.

PMID:
27891625
35.

Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.

Sonneveld ME, Koelewijn J, de Haas M, Admiraal J, Plomp R, Koeleman CA, Hipgrave Ederveen AL, Ligthart P, Wuhrer M, van der Schoot CE, Vidarsson G.

Br J Haematol. 2017 Feb;176(4):651-660. doi: 10.1111/bjh.14438. Epub 2016 Nov 28.

PMID:
27891581
36.

Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes.

Thurik FF, Lamain-de Ruiter M, Javadi A, Kwee A, Woortmeijer H, Page-Christiaens GC, Franx A, van der Schoot CE, Koster MP.

Prenat Diagn. 2016 Dec;36(12):1104-1111. doi: 10.1002/pd.4940. Epub 2016 Nov 10.

PMID:
27734510
37.

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences.

Waanders E, Scheijen B, Jongmans MC, Venselaar H, van Reijmersdal SV, van Dijk AH, Pastorczak A, Weren RD, van der Schoot CE, van de Vorst M, Sonneveld E, Hoogerbrugge N, van der Velden VH, Gruhn B, Hoogerbrugge PM, van Dongen JJ, Geurts van Kessel A, van Leeuwen FN, Kuiper RP.

Leukemia. 2017 Apr;31(4):821-828. doi: 10.1038/leu.2016.277. Epub 2016 Oct 13.

PMID:
27733777
38.

International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

Storry JR, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Keller M, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Peyrard T, van der Schoot CE, Tani Y, Thornton N, Wagner F, Wendel S, Westhoff C, Yahalom V.

ISBT Sci Ser. 2016 Aug;11(2):118-122. doi: 10.1111/voxs.12280. Epub 2016 Jun 27.

39.

Identification of a novel frequent RHCE*ce308T variant allele in Chinese D- individuals, resulting in a C+c- phenotype.

Stegmann TC, Ji Y, Bijman R, Wang Z, Wen J, Wei L, Veldhuisen B, Haer-Wigman L, Lighthart P, Lodén-van Straaten M, Luo G, van der Schoot CE.

Transfusion. 2016 Sep;56(9):2314-21. doi: 10.1111/trf.13709. Epub 2016 Jun 24.

PMID:
27338008
40.

Fetal RHD genotyping after bone marrow transplantation.

Thurik FF, Page-Christiaens GC, Ait Soussan A, Ligthart PC, Cheroutre GM, Bossers B, Veldhuisen B, van der Schoot CE, de Haas M.

Transfusion. 2016 Aug;56(8):2122-6. doi: 10.1111/trf.13669. Epub 2016 May 30.

PMID:
27239725
41.

Different Balance of Wnt Signaling in Adult and Fetal Bone Marrow-Derived Mesenchymal Stromal Cells.

Paciejewska MM, Maijenburg MW, Gilissen C, Kleijer M, Vermeul K, Weijer K, Veltman JA, von Lindern M, van der Schoot CE, Voermans C.

Stem Cells Dev. 2016 Jun 15;25(12):934-47. doi: 10.1089/scd.2015.0263.

PMID:
27154244
42.

Erratum to: The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.

Sonneveld ME, van der Schoot CE, Vidarsson G.

J Clin Immunol. 2016 May;36(Suppl 1):82. No abstract available.

PMID:
27121694
43.

Prediction of the anti-RhD donor population size for managerial decision-making.

van Hoeven LR, Berkowska MA, Verhagen OJ, Koffijberg H, van der Schoot CE, Janssen MP.

Vox Sang. 2016 Aug;111(2):171-7. doi: 10.1111/vox.12400. Epub 2016 Apr 14.

PMID:
27077781
44.

Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.

Stegmann TC, Veldhuisen B, Bijman R, Thurik FF, Bossers B, Cheroutre G, Jonkers R, Ligthart P, de Haas M, Haer-Wigman L, van der Schoot CE.

Br J Haematol. 2016 May;173(3):469-79. doi: 10.1111/bjh.13960. Epub 2016 Mar 27.

PMID:
27018217
45.

Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.

Sonneveld ME, Natunen S, Sainio S, Koeleman CA, Holst S, Dekkers G, Koelewijn J, Partanen J, van der Schoot CE, Wuhrer M, Vidarsson G.

Br J Haematol. 2016 Jul;174(2):310-20. doi: 10.1111/bjh.14053. Epub 2016 Mar 28.

PMID:
27017954
46.

The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.

Sonneveld ME, van der Schoot CE, Vidarsson G.

J Clin Immunol. 2016 May;36 Suppl 1:76-81. doi: 10.1007/s10875-016-0253-x. Epub 2016 Mar 10. Review. Erratum in: J Clin Immunol. 2016 May;36 Suppl 1:82.

PMID:
26961360
47.

Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.

van Wezel EM, Decarolis B, Stutterheim J, Zappeij-Kannegieter L, Berthold F, Schumacher-Kuckelkorn R, Simon T, Fiocco M, van Noesel MM, Caron HN, van der Schoot CE, Hero B, Tytgat GAM.

Eur J Cancer. 2016 Feb;54:149-158. doi: 10.1016/j.ejca.2015.11.007. Epub 2016 Jan 12.

PMID:
26796600
48.
49.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.

Eleveld TF, Oldridge DA, Bernard V, Koster J, Colmet Daage L, Diskin SJ, Schild L, Bentahar NB, Bellini A, Chicard M, Lapouble E, Combaret V, Legoix-Né P, Michon J, Pugh TJ, Hart LS, Rader J, Attiyeh EF, Wei JS, Zhang S, Naranjo A, Gastier-Foster JM, Hogarty MD, Asgharzadeh S, Smith MA, Guidry Auvil JM, Watkins TB, Zwijnenburg DA, Ebus ME, van Sluis P, Hakkert A, van Wezel E, van der Schoot CE, Westerhout EM, Schulte JH, Tytgat GA, Dolman ME, Janoueix-Lerosey I, Gerhard DS, Caron HN, Delattre O, Khan J, Versteeg R, Schleiermacher G, Molenaar JJ, Maris JM.

Nat Genet. 2015 Aug;47(8):864-71. doi: 10.1038/ng.3333. Epub 2015 Jun 29.

50.

Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma.

van Wezel EM, Stutterheim J, Vree F, Zappeij-Kannegieter L, Decarolis B, Hero B, Berthold F, Schumacher-Kuckelkorn R, Simon T, Fiocco M, Voermans C, van Noesel MM, Caron HN, van der Schoot CE, Tytgat GA; GPOH MRD Study Group.

Pediatr Blood Cancer. 2015 Aug;62(8):1368-73. doi: 10.1002/pbc.25507. Epub 2015 May 4.

PMID:
25939774

Supplemental Content

Loading ...
Support Center